Five measures the FDA plans to take:
- Further development of regulatory framework, including draft guidance on a change control plan for AI’s learning over time
- Working toward the unified development of good machine learning practices to assess and improve AI algorithms
- Advocating for a patient-centric approach to AI design, including delivering device transparency to users
- Creating strategies to effectively evaluate and improve AI algorithms
- Supporting the expansion of real-world performance monitoring pilots
More articles on artificial intelligence:
MUSC creates AI tool to predict patients’ risks for COVID-19 complications
3 recent studies exploring medical AI tools’ efficacy
Children’s National Hospital, NIH launch COVID-19 diagnostics AI challenge
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
